OBJECTIVES: Meningoencephalitis caused by Cryptococcus gattii is associated with significant morbidity and the need for aggressive therapy, and often necessitates neurosurgical intervention. We adapted a previously described murine model of cryptococcal meningoencephalitis due to Cryptococcus neoformans to that caused by C. gattii. METHODS: Mice were inoculated intracranially with either C. gattii (genotype VGIIa) or C. neoformans. In virulence studies, different C. gattii infecting inocula were compared with a fixed inoculum of C. neoformans, and differences were assessed by survival, brain tissue fungal burden, serum antigen titres and histopathological changes within brain tissue. For treatment, fluconazole or posaconazole (10 mg/kg orally twice daily) was initiated 24 h post-inoculation. RESULTS: C. gattii was more virulent than C. neoformans, as evident by shorter median survival, earlier histopathological changes and higher serum antigen titres. However, no differences in fungal burden or dissemination to other organs were observed among the various groups. In treatment studies, both fluconazole and posaconazole improved the median survival of mice infected with either species. However, neither regimen improved the percentage of animals surviving to the predetermined study endpoint. CONCLUSIONS: These results demonstrate the virulence of C. gattii meningoencephalitis and the potential of this model for the assessment of new treatment strategies.
OBJECTIVES:Meningoencephalitis caused by Cryptococcus gattii is associated with significant morbidity and the need for aggressive therapy, and often necessitates neurosurgical intervention. We adapted a previously described murine model of cryptococcal meningoencephalitis due to Cryptococcus neoformans to that caused by C. gattii. METHODS:Mice were inoculated intracranially with either C. gattii (genotype VGIIa) or C. neoformans. In virulence studies, different C. gattii infecting inocula were compared with a fixed inoculum of C. neoformans, and differences were assessed by survival, brain tissue fungal burden, serum antigen titres and histopathological changes within brain tissue. For treatment, fluconazole or posaconazole (10 mg/kg orally twice daily) was initiated 24 h post-inoculation. RESULTS:C. gattii was more virulent than C. neoformans, as evident by shorter median survival, earlier histopathological changes and higher serum antigen titres. However, no differences in fungal burden or dissemination to other organs were observed among the various groups. In treatment studies, both fluconazole and posaconazole improved the median survival of mice infected with either species. However, neither regimen improved the percentage of animals surviving to the predetermined study endpoint. CONCLUSIONS: These results demonstrate the virulence of C. gattiimeningoencephalitis and the potential of this model for the assessment of new treatment strategies.
Authors: J C Ding; M Bauer; D M Diamond; M A Leal; D Johnson; B K Williams; A M Thomas; L Najvar; J R Graybill; R A Larsen Journal: Antimicrob Agents Chemother Date: 1997-07 Impact factor: 5.191
Authors: D M Diamond; M Bauer; B E Daniel; M A Leal; D Johnson; B K Williams; A M Thomas; J C Ding; L Najvar; J R Graybill; R A Larsen Journal: Antimicrob Agents Chemother Date: 1998-03 Impact factor: 5.191
Authors: S E Kidd; F Hagen; R L Tscharke; M Huynh; K H Bartlett; M Fyfe; L Macdougall; T Boekhout; K J Kwon-Chung; W Meyer Journal: Proc Natl Acad Sci U S A Date: 2004-11-30 Impact factor: 11.205
Authors: D H Mitchell; T C Sorrell; A M Allworth; C H Heath; A R McGregor; K Papanaoum; M J Richards; T Gottlieb Journal: Clin Infect Dis Date: 1995-03 Impact factor: 9.079
Authors: Leona T Campbell; Anna R Simonin; Cuilan Chen; Jannatul Ferdous; Matthew P Padula; Elizabeth Harry; Markus Hofer; Iain L Campbell; Dee A Carter Journal: Eukaryot Cell Date: 2015-04-03
Authors: Nathan P Wiederhold; Laura Kovanda; Laura K Najvar; Rosie Bocanegra; Marcos Olivo; William R Kirkpatrick; Thomas F Patterson Journal: Antimicrob Agents Chemother Date: 2016-08-22 Impact factor: 5.191
Authors: Nathan P Wiederhold; Laura K Najvar; Rosie Bocanegra; William R Kirkpatrick; Tania C Sorrell; Thomas F Patterson Journal: Antimicrob Agents Chemother Date: 2012-11-19 Impact factor: 5.191
Authors: Nathan P Wiederhold; Laura K Najvar; Edward P Garvey; Stephen R Brand; Xin Xu; Elizabeth A Ottinger; Asaf Alimardanov; Jim Cradock; Mark Behnke; William J Hoekstra; Robert J Schotzinger; Rosie Jaramillo; Marcos Olivo; William R Kirkpatrick; Thomas F Patterson Journal: Antimicrob Agents Chemother Date: 2018-08-27 Impact factor: 5.191
Authors: Mai Lee Yang; John Uhrig; Kiem Vu; Anil Singapuri; Michael Dennis; Angie Gelli; George R Thompson Journal: Antimicrob Agents Chemother Date: 2015-12-07 Impact factor: 5.191
Authors: Nathan P Wiederhold; Xin Xu; Amy Wang; Laura K Najvar; Edward P Garvey; Elizabeth A Ottinger; Asaf Alimardanov; Jim Cradock; Mark Behnke; William J Hoekstra; Stephen R Brand; Robert J Schotzinger; Rosie Jaramillo; Marcos Olivo; William R Kirkpatrick; Thomas F Patterson Journal: Antimicrob Agents Chemother Date: 2018-10-24 Impact factor: 5.191